Hackers Exploit AI Like GPT-4 for Autonomous Malware and Cyber Threats WebProNews

FDA approves breast cancer drug
The FDA has approved Eli Lilly’s imlunestrant, an oral estrogen receptor antagonist, for the treatment of adults with estrogen receptor positive, HER2-negative, ESR1-mutated advanced or